Tellus BioVentures
Overview
Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation. The fund uncovers and accelerates promising life science innovations and enables talented entrepreneurs and innovators to bring their ideas to fruition. They make select investments at the Seed stage and participate in Series-A investments, often as lead or sole investors. Their mission is to serve patients with unmet needs by launching and funding new biotech ventures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hangzhou DAC Biotechnology Co., Ltd. | May 2021 | Series C | Co-investor |
| Cantai Therapeutics | Nov 2023 | Seed | Co-investor |
| Aegle Therapeutics Corp | Oct 2020 | Grant | Co-investor |
| Praeventix | Nov 2022 | Seed | Co-investor |
| Vittoria Biotherapeutics | Nov 2024 | Private Financing Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tellus BioVentures based?
Tellus BioVentures is headquartered in Florida.
When was Tellus BioVentures founded?
Tellus BioVentures was founded in 2019.
How many portfolio companies does Tellus BioVentures have?
Tellus BioVentures has 6 portfolio companies in Caplight's dataset.
What are some companies in Tellus BioVentures's portfolio?
Portfolio companies visible on Caplight include Hangzhou DAC Biotechnology Co., Ltd., Cantai Therapeutics, Aegle Therapeutics Corp, Praeventix, Vittoria Biotherapeutics.
What was Tellus BioVentures's most recent investment shown here?
Tellus BioVentures's most recent investment in this portfolio sample was in Vittoria Biotherapeutics in 2024.
What sectors does Tellus BioVentures focus on?
Tellus BioVentures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Tellus BioVentures focus on?
Tellus BioVentures typically invests at the Early stage.
What is Tellus BioVentures's AUM?
Tellus BioVentures's assets under management are estimated between $0.0 and $50.0M.